Tax
Income Tax
Regeneron Pharmaceuticals Income Tax decreased by 47.8% to $104.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 8.0%, from $96.30M to $104.00M. Over 4 years (FY 2021 to FY 2025), Income Tax shows a downward trend with a -12.7% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementIncome Statement
SectionTax
CategoryRisk
SignalLower is better
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026
How to read this metric
Changes may reflect shifts in corporate tax law, geographic earnings mix, or the expiration of tax incentives.
Detailed definition
The total amount of income tax a company expects to pay to federal, state, and foreign governments based on its earnings...
Peer comparison
Global companies often have complex tax expenses due to earnings in multiple international jurisdictions.
Metric ID:
income_tax_expenseHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $653.90M | $184.40M | $274.40M | $87.60M | $111.10M | $194.10M | $127.60M | $40.20M | $114.50M | $103.00M | $0.00 | -$21.30M | $195.80M | $152.40M | $40.40M | $96.30M | $127.10M | $303.30M | $199.10M | $104.00M |
| QoQ Change | — | -71.8% | +48.8% | -68.1% | +26.8% | +74.7% | -34.3% | -68.5% | +184.8% | -10.0% | -100.0% | — | >999% | -22.2% | -73.5% | +138.4% | +32.0% | +138.6% | -34.4% | -47.8% |
| YoY Change | — | — | — | — | -83.0% | +5.3% | -53.5% | -54.1% | +3.1% | -46.9% | -100.0% | -153.0% | +71.0% | +48.0% | — | +552.1% | -35.1% | +99.0% | +392.8% | +8.0% |
Range-$21.30M – $653.90M
CAGR-32.1%
Avg YoY Growth+43.6%
Median YoY Growth+3.1%
Current Streak2 quarters decline
Income Tax at Other Companies
Frequently Asked Questions
- What is Regeneron Pharmaceuticals's income tax?
- Regeneron Pharmaceuticals (REGN) reported income tax of $104.00M in Q1 2026.
- How has Regeneron Pharmaceuticals's income tax changed year-over-year?
- Regeneron Pharmaceuticals's income tax increased by 8.0% year-over-year, from $96.30M to $104.00M.
- What is the long-term trend for Regeneron Pharmaceuticals's income tax?
- Over 4 years (2021 to 2025), Regeneron Pharmaceuticals's income tax has grown at a -12.7% compound annual growth rate (CAGR), from $1.25B to $725.80M.
- What does income tax mean?
- The amount of money a company sets aside to pay its corporate income taxes.